Related coverage linked through entity extraction aliases.
Jul 28, 2026
Sheba Medical Center becomes first hospital outside the US to adopt OpenAI's healthcare AI models. Jerusalem launches FourWard medical innovation hub, and international health leaders visit Israeli labs to study medical innovation.
Jul 28, 2026
More than 80% of U.S. physicians use AI in their work. AI is revealing new cardiac biomarkers and speeding drug discovery, with the healthcare AI market projected to reach $505.6 billion by 2033—but studies warn of bias and eroding critical thinking.
Jul 31, 2026
Benchmark studies show general-purpose LLMs like GPT-5.2, Gemini 3.1 Pro, and Claude Opus 4.6 outperform FDA-cleared clinical AI tools and physicians on diagnostic reasoning tasks. Domain-adapted LLMs also beat larger generic models on clinical research tasks, while agentic systems show only modest gains. Regulatory clearance pathways have not yet addressed comparative performance.
Jul 07, 2026
Novo Nordisk partners with OpenAI to speed drug discovery, with pilots by 2026. AI is moving beyond hype into pharma R&D, reflected in major collaborations and new FDA guidance.
Jul 19, 2026
Semiconductor stocks surged as Intel, AMD, and POET hit fresh highs on AI infrastructure demand, while SemiLEDS jumped 17.96% after a Q3 turnaround. Intel posted stronger-than-expected Q1 earnings and upbeat Q2 guidance.
May 20, 2026
Bristol Myers Squibb will deploy Anthropic’s Claude across global operations, putting the AI platform in the hands of more than 30,000 employees. BMS plans to use it in R&D, clinical development, manufacturing and commercial work.
May 10, 2026
Thrive Capital has raised more than $10 billion in its largest fund ever. The fundraising was heavily oversubscribed and the cash influx was double the size of its last fund.
Apr 12, 2026
Generative AI processed complex medical datasets faster than traditional teams in a preterm birth study, while the healthcare market for the technology reached US$2.92 billion in 2024. The market is projected to grow to US$30.68 billion by 2033 as adoption expands in clinical workflows, imaging, drug discovery and precision medicine.
Apr 03, 2026
Recent studies reveal AI chatbots face significant challenges in medical applications, with one study showing ChatGPT Health under-triaged 51.6% of emergency cases. Cancer patients using an AI chatbot experienced 22% withdrawal rates due to usability issues, while medical researchers show cautious adoption with 40.3% reporting AI use in research.
Mar 25, 2026
OpenAI Foundation has pledged $1 billion in grants over the next year to support life science and health research while addressing AI's impacts on jobs and mental health. The nonprofit will recruit a new executive director to oversee grantmaking as part of its revitalized philanthropic mission.
Feb 21, 2026
Eighty-six countries including the US and China signed a declaration calling for secure and trustworthy AI at the five-day AI Impact Summit in New Delhi, though the statement included no concrete regulatory commitments and drew criticism for being too generic.
Feb 13, 2026
Isomorphic Labs introduced IsoDDE, a drug discovery engine that outperforms AlphaFold 3 by a factor of two in prediction accuracy. Google also updated Gemini 3 Deep Think, which now outperforms competing models in complex scientific tasks.
